"Haifong Biomedical" Rivaroxaban correction solution group - Taiwan Registration b748b8f112fad3756c9c3edb4306233d

Access comprehensive regulatory information for "Haifong Biomedical" Rivaroxaban correction solution group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b748b8f112fad3756c9c3edb4306233d and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.